Compare Applovin Corporation (APP) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applovin Corporation vs GSK plc — how do they compare? Applovin Corporation trades at $318.86 (market cap $106.65B), while GSK plc trades at $50.56 (market cap $102.60B). The key difference: Applovin Corporation and GSK plc are close in size by market cap, and GSK plc pays a 3.57% dividend while Applovin Corporation pays none. Which is the better fit depends on your goals.
| APP | GSK | |
|---|---|---|
Market Cap | $106.65B | $102.60B |
Sector | Technology | Health |
52-Week High | $733.60 | $61.18 |
52-Week Low | $318.68 | $38.22 |
Enterprise Value | $107.11B | $123.04B |
Dividend Yield | — | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applovin Corporation
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
